Citation 80188

CHANG,FR: YANG,PY: LIN,JY: LEE,KH: WU,YC:. (1998). BIOACTIVE KAURANE DITERPENOIDS FROM ANNONA GLABRA.. 61(4)

Citation Details

Title	BIOACTIVE KAURANE DITERPENOIDS FROM ANNONA GLABRA.
Authors	CHANG,FR: YANG,PY: LIN,JY: LEE,KH: WU,YC:
Year	1998
Volume	61
Issue	4

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Annona glabra (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOGLABASIN A	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANNOGLABASIN A	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOGLABASIN A	INACTIVE
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ANNOGLABASIN B	None
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANNOGLABASIN B	INACTIVE
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANNOGLABASIN B	INACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAUR-16-EN-19-OIC ACID,ENT: (-):	None
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAUR-16-EN-19-OIC ACID,ENT: (-):	INACTIVE
9	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT: (-):	INACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-HYDRO-19-ACETOXY: ENT: (-):	None
11	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-17-OIC ACID,16-HYDRO-19-ACETOXY: ENT: (-):	INACTIVE
12	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-HYDRO-19-ACETOXY: ENT: (-):	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-OIC ACID,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	None
14	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-19-OIC ACID,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	WEAK ACTIVITY
15	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-OIC ACID,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	INACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-BETA-HYDRO: ENT: (-):	None
17	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-17-OIC ACID,16-BETA-HYDRO: ENT: (-):	WEAK ACTIVITY
18	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-BETA-HYDRO: ENT: (-):	INACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-ALPHA-HYDRO: ENT: (-):	None
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-17-OIC ACID,16-ALPHA-HYDRO: ENT: (-):	INACTIVE
21	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO: ENT: (-):	INACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAUR-16-EN-19-OL,ENT: (-):	None
23	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAUR-16-EN-19-OL,ENT: (-):	INACTIVE
24	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OL,ENT: (-):	EQUIVOCAL
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAUR-15-ENE-17-19-DIOL,ENT: (-):	None
26	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAUR-15-ENE-17-19-DIOL,ENT: (-):	INACTIVE
27	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-15-ENE-17-19-DIOL,ENT: (-):	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: (-):	None
29	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: (-):	INACTIVE
30	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: (-):	EQUIVOCAL
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: METHYL ESTER	None
32	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: METHYL ESTER	ACTIVE
33	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-17-OIC ACID,16-ALPHA-HYDRO-19-AL-ENT: METHYL ESTER	INACTIVE
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-19-AL,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	None
35	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-19-AL,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	INACTIVE
36	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-19-AL,16-BETA-HYDROXY-17-ACETOXY: ENT: (-):	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURAN-4-ALPHA-OL-17-OIC ACID,19-NOR: ENT: (-):	None
38	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-4-ALPHA-OL-17-OIC ACID,19-NOR: ENT: (-):	INACTIVE
39	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAURAN-4-ALPHA-OL-17-OIC ACID,19-NOR: ENT: (-):	INACTIVE

Citation 80188

Citation Details

Summary

Organisms and Their Experiments (1)

Annona glabra (ANNONACEAE)

Show SPARQL Queries (1)

Query 1